Neuro-Oncological Diseases Device Market Demand Overview, Growth Innovation, Latest Trends till 2029 by Key Players | Siemens Healthcare , Philips Healthcare , Canon Medical Systems , GE Healthcare

Latest Study on Industrial Growth of Neuro-Oncological Diseases Device Market 2023-2029. A detailed study accumulated to offer Latest insights about acute features of the Neuro-Oncological Diseases Device Market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary and SWOT analysis.

The global non-oncology precision medicine market was estimated at USD 70,160 million in 2022 and is expected to surpass around USD 1,63,500 million by 2029, registering a healthy CAGR of 8.7% from 2023 to 2029.

Key Players in This Report Include:

Siemens Healthcare, Philips Healthcare, Canon Medical Systems, GE Healthcare, Hitachi Medical

Industry News:

Siemens has acquired 56 companies, including 15 in the last 5 years. A total of 20 acquisitions came from private equity firms. It has also divested 23 assets.Siemens' largest acquisition to date was in 2015, when it acquired Dresser-Rand Group for $7.8B. It's largest disclosed sale occurred in 2014, when it sold Sivantos Group to EQT Holdings AB for $2.4B. Siemens has acquired in 13 different US states, and 12 countries. The Company's most targeted sectors include software (46%) and information technology (8%)

GE Healthcare has acquired 31 companies, including 5 in the last 5 years. A total of 11 acquisitions came from private equity firms. It has also divested 11 assets. GE Healthcare's largest acquisition to date was in 2021, when it acquired BK Medical Holding Company for $1.5B. It's largest disclosed sale occurred in 2018, when it sold Virence Health Technologies to Veritas Capital for $1.1B. GE Healthcare has acquired in 11 different US states, and 6 countries. The Company's most targeted sectors include medical products (42%) and healthcare services (21%).

Philips has acquired 37 companies, including 7 in the last 5 years. A total of 14 acquisitions came from private equity firms. It has also divested 14 assets.Philips' largest acquisition to date was in 2007, when it acquired Respironics for $5.1B. It's largest disclosed sale occurred in 2021, when it sold Koninklijke Philips - Domestic Appliances Business to Hillhouse Capital Management for $3.7B. Philips has acquired in 12 different US states, and 10 countries. The Company's most targeted sectors include medical products (40%) and electrical equipment (10%).

Download Free Sample Report PDF (Including Full TOC, Table & Figures):

https://www.marketintelligencedata.com/reports/7260904/neuro-oncological-diseases-device-market-research-reports-providing-in-depth-market-analysis-and-industry-forecasts-2023-2029/inquiry?Mode=S74

The Neuro-Oncological Diseases Device market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.

The Neuro-Oncological Diseases Device Market segments and Market Data Break Down are illuminated below

By Type:

MRI

CT Scan

PET

Others

By Application:

Hospitals

Clinics

Diagnostics Centers

Reference Laboratories

Medical Research Institutes

Others

Global Neuro-Oncological Diseases Device market report highlights information regarding the current and future industry trends, growth patterns, as well as it offers business strategies to help the stakeholders in making sound decisions that may help to ensure the profit trajectory over the forecast years.

Have a query? Market an enquiry before purchase:

https://www.marketintelligencedata.com/reports/7260904/neuro-oncological-diseases-device-market-research-reports-providing-in-depth-market-analysis-and-industry-forecasts-2023-2029?Mode=S74

Following are the various regions covered by the Neuro-Oncological Diseases Device Market research report:

North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Russia, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, and Rest of APAC), South America (Brazil, Argentina, Columbia and Rest of Latin America), Middle East & Africa (Saudi Arabia, South Africa, Turkey, Nigeria, UAE and Rest of MEA)

Increasing prevalence of pituitary tumors throughout Europe is expected to drive the neuro endoscopy market in Europe. A number of major companies such as B Braun and Karl Storz are located in North America, which is driving regional growth. Meanwhile, increasing incidence of acute pediatric brain tumors will further expand market size. Furthermore, the rising demand for minimally invasive procedures among the population also contributes to the dominance of North America market shares during the analysis period.

In addition to growing brain tumor prevalences as well as increasing non-invasive biopsies at the medical facilities, Asia Pacific neuroendoscopy market growth will be strongly augmented by escalating healthcare expenditures of rapidly developing economies including India, Vietnam, and others.

People above the age of 65 years are particularly at risk of developing brain tumors, in fact, glioblastoma is the most common primary brain tumor prevalent among the geriatric population. The growing number of elderly people across countries like India and China will lead to significant market growth in neuroendoscopy devices.

Objectives of the Report

To carefully analyses and forecast the size of the market by value and volume.
To estimate the market shares of major segments of the Neuro-Oncological Diseases Device
To showcase the development of the market in different parts of the world.
To analyze and study micro-markets in terms of their contributions to the Neuro-Oncological Diseases Device market, their prospects, and individual growth trends.
To offer precise and useful details about factors affecting the growth of the Neuro-Oncological Diseases Device
To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Neuro-Oncological Diseases Device market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.

Buy Now Link:

https://www.marketintelligencedata.com/report/purchase/7260904?mode=su?Mode=S74

Key Points Covered in Market Report:

-Market Overview, Definition and Classification Market drivers and barriers

-Market Competition by Manufacturers

-Impact Analysis of COVID-19 on Market

-Market Capacity, Production, Revenue (Value) by region (2023-2029)

-Neuro-Oncological Diseases Device Supply (Production), Consumption, Export, Import by Region (2023-2029)

- Neuro-Oncological Diseases Device market Production, Revenue (Value), Price Trend by Type {Payment Gateway, Merchant Account, Subscription Management,}

-Neuro-Oncological Diseases Device Manufacturers Profiles/Analysis & Manufacturing Cost Analysis, Industrial/Supply Chain Analysis, Sourcing Strategy and Downstream Buyers, Marketing

-Strategy by Key Manufacturers/Players, Connected Distributors/Traders Standardization, Regulatory and collaborative initiatives, Industry Road map and value chain Market Effect Factors Analysis.

Key questions answered
- How feasible is Neuro-Oncological Diseases Device market for long-term investment?
- What are influencing factors driving the demand for Neuro-Oncological Diseases Device near future?
- What is the impact analysis of various factors in the Global Neuro-Oncological Diseases Device market growth?
- What are the recent trends in the regional Neuro-Oncological Diseases Device market and how successful they are?

We offer customization on the Neuro-Oncological Diseases Device market report based on specific client requirements:

20% free customization.
Five Countries can be added as per your choice.
Five Companies can add as per your choice.
Free customization for up to 40 hours.
After-sales support for 1 year from the date of delivery.

Thank you for your interest in the Neuro-Oncological Diseases Device Market research publications; you can also get individual chapters or regional/country report versions such as Germany, France, China, Latin America, GCC, North America, Europe or Asia.

About Us:

Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact us:

Irfan Tamboli (Head of Sales) - Market Intelligence Data

Phone: +1 (704) 266-3234 | +91-750-707-8687

Mail to: sales@marketintelligencedata.com

This release was published on openPR.